Global The global contract manufacturing market is booming, but fragmented. The well-established names of the CDMO space – Lonza, Thermo Fisher, WuXi AppTec, WuXi Biologics, and Samsung Biologics – account for just 15 percent of total revenues. Beyond these giants, a huge network of smaller, more specialised CDMOs are, in…
Germany Axolabs has spent more than two decades building expertise in a field that is only now beginning to reach greater clinical and commercial scale. Under CEO Susanne Leonhartsberger, the specialist oligonucleotide CRDMO is bringing that scientific heritage together with a substantially expanded manufacturing footprint, including its major new facility in…
See our Cookie Privacy Policy Here
